Börsipäev 26.detsember
Log in or create an account to leave a comment
-
Häid jätkuvaid jõulupühi kõigile LHV foorumlastele!
Enamus aktsiaturge on täna endiselt pühade tõttu suletud, aga USA turud on avatud ja kauplevad tavapärasel ajal 17.00-23.00.
Pühade ajal on turuosalised natuke elu üle järele mõelnud ja otsustanud aasta lõpus kasumit võtta. Nasdaqi futuurid on kauplemas 0,66% miinuspoolel ja ES ning Dow Jones 0,2% madalamal. -
Gapping up
M&A:
SCMP (+5%) Acquired by Mallinckrodt (MNK)
News:
IGC (+180%) Developing leverage existing assets to develop methods to utilize blockchain
DMPI (+44%) FDA has granted Fast Track designation for the company's lead product candidate, VAL-083, in recurrent glioblastoma
APTO (+37%) FDA grants orphan drug designation for CG'806 in Acute Myeloid Leukemia
ONVO (+10%) FDA granted orphan drug designation for the Company's treatment of alpha-1 antitrypsin deficiency with its 3D bioprinted liver therapeutic tissue
KED (+4%) Tax Cuts have positive impact on NAV
Crypto stocks:
IGC +172.36% LFIN +15.78% NETE +14.35% FTFT +12.64% RIOT +10.11% ONVO +7.59% OTIV +7.48% NXTD +7.48% TEUM +7.09% MARA +6.31% SIEB +5.83% DPW +4.87% JTPY +5.08% GLNNF +4.03% SRAX +3.14% OSTK +3.12% SSC +3.00% XNET +2.86% GROW +2.46% MGTI +1.43%
Gapping down
AAPL -2.5% on reports of on reports out of Taiwan for reduced iPhone X orders
Suppliers (SMH): LITE -3% SWKS -2.8%, QRVO -2.5%, CRUS -2.4%, FNSR -2%, MU -1.8%, AVGO -1.6%, JBL --1.5%, AMAT -1.3%, XLNX -0.6%, OLED -1%, TXN -0.3%
Other tech stocks indicated lower (QQQ): NVDA -1%, AMD -1%, MSFT -0.5%
News:
PTLA (-5%) FDA will extend its review of the Biologics License Application for AndexXa by 90 days
Analyst comments:
AGRX (-8%) downgraded at Janney and William Blair after receiving complete response letter from the FDA for Twirla on Friday morning
Briefing.com -
The blue-chip index climbed 1,086 points, or 5%, to 22878, its largest one-day percentage gain since March 2009. The S&P 500 added 5%, led by the consumer-discretionary and technology groups that powered the index higher for much of the year. The tech-heavy Nasdaq Composite rose 5.8%.
